283 related articles for article (PubMed ID: 16477220)
1. Conversion to sirolimus and mycophenolate can attenuate the progression of bronchiolitis obliterans syndrome and improves renal function after lung transplantation.
Groetzner J; Wittwer T; Kaczmarek I; Ueberfuhr P; Strauch J; Nagib R; Meiser B; Franke U; Reichart B; Wahlers T
Transplantation; 2006 Feb; 81(3):355-60. PubMed ID: 16477220
[TBL] [Abstract][Full Text] [Related]
2. Renal recovery after conversion to a calcineurin inhibitor-free immunosuppression in late cardiac transplant recipients.
Groetzner J; Kaczmarek I; Landwehr P; Mueller M; Daebritz S; Lamm P; Meiser B; Reichart B
Eur J Cardiothorac Surg; 2004 Mar; 25(3):333-41. PubMed ID: 15019657
[TBL] [Abstract][Full Text] [Related]
3. Effects of prophylactic use of sirolimus on bronchiolitis obliterans syndrome development in lung transplant recipients.
Sacher VY; Fertel D; Srivastava K; Panos A; Nguyen D; Baxter T; Shafazand S; Pham SM
Ann Thorac Surg; 2014 Jan; 97(1):268-74. PubMed ID: 24119986
[TBL] [Abstract][Full Text] [Related]
4. Mycophenolate mofetil and sirolimus as calcineurin inhibitor-free immunosuppression for late cardiac-transplant recipients with chronic renal failure.
Groetzner J; Meiser B; Landwehr P; Buehse L; Mueller M; Kaczmarek I; Vogeser M; Daebritz S; Ueberfuhr P; Reichart B
Transplantation; 2004 Feb; 77(4):568-74. PubMed ID: 15084937
[TBL] [Abstract][Full Text] [Related]
5. Mycophenolate and sirolimus as calcineurin inhibitor-free immunosuppression improves renal function better than calcineurin inhibitor-reduction in late cardiac transplant recipients with chronic renal failure.
Groetzner J; Kaczmarek I; Schulz U; Stegemann E; Kaiser K; Wittwer T; Schirmer J; Voss M; Strauch J; Wahlers T; Sohn HY; Wagner F; Tenderich G; Stempfle HU; Mueller-Ehmsen J; Schmid C; Vogeser M; Koch KC; Reichenspurner H; Daebritz S; Meiser B; Reichart B;
Transplantation; 2009 Mar; 87(5):726-33. PubMed ID: 19295318
[TBL] [Abstract][Full Text] [Related]
6. Preoperative introduction and maintenance immunosuppression therapy of oral-only tacrolimus, mycophenolate mofetil and steroids reduce acute rejection episodes after lung transplantation.
Bittner HB; Barten MJ; Binner C; Lehmann S; Garbade J; Hammerschmidt S; Wirtz H; Mohr FW
Eur J Cardiothorac Surg; 2010 Sep; 38(3):268-76. PubMed ID: 20304665
[TBL] [Abstract][Full Text] [Related]
7. Calcineurin inhibitors in bronchiolitis obliterans syndrome following stem cell transplantation.
Hostettler KE; Halter JP; Gerull S; Lardinois D; Savic S; Roth M; Tamm M
Eur Respir J; 2014 Jan; 43(1):221-32. PubMed ID: 23645405
[TBL] [Abstract][Full Text] [Related]
8. Sirolimus and mycophenolate mofetil after liver transplantation.
Kniepeiss D; Iberer F; Grasser B; Schaffellner S; Tscheliessnigg KH
Transpl Int; 2003 Jul; 16(7):504-9. PubMed ID: 12687325
[TBL] [Abstract][Full Text] [Related]
9. Mycophenolate mofetil reduces alveolar inflammation, acute rejection and graft loss due to bronchiolitis obliterans syndrome after lung transplantation.
Speich R; Schneider S; Hofer M; Irani S; Vogt P; Weder W; Boehler A
Pulm Pharmacol Ther; 2010 Oct; 23(5):445-9. PubMed ID: 20394831
[TBL] [Abstract][Full Text] [Related]
10. Everolimus in lung transplantation in Chile.
Parada MT; Alba A; Sepúlveda C
Transplant Proc; 2010; 42(1):328-30. PubMed ID: 20172343
[TBL] [Abstract][Full Text] [Related]
11. Conversion from calcineurin inhibitor to either mycophenolate mofetil or sirolimus improves renal function in liver transplant recipients with chronic kidney disease: results of a prospective randomized trial.
Herlenius G; Felldin M; Nordén G; Olausson M; Bäckman L; Gustafsson B; Friman S
Transplant Proc; 2010 Dec; 42(10):4441-8. PubMed ID: 21168715
[TBL] [Abstract][Full Text] [Related]
12. Calcineurin inhibitor withdrawal and conversion to mycophenolate mofetil and steroids in cardiac transplant recipients with chronic renal failure: a word of caution.
Groetzner J; Kaczmarek I; Schirmer J; Uberfuhr P; Gulbins H; Daebritz S; Meiser B; Reichart B
Clin Transplant; 2008; 22(5):587-93. PubMed ID: 18460000
[TBL] [Abstract][Full Text] [Related]
13. Comparison of mycophenolate mofetil and azathioprine for prevention of bronchiolitis obliterans syndrome in de novo lung transplant recipients.
McNeil K; Glanville AR; Wahlers T; Knoop C; Speich R; Mamelok RD; Maurer J; Ives J; Corris PA
Transplantation; 2006 Apr; 81(7):998-1003. PubMed ID: 16612275
[TBL] [Abstract][Full Text] [Related]
14. Kidney transplantation with sirolimus and mycophenolate mofetil-based immunosuppression: 5-year results of a randomized prospective trial compared to calcineurin inhibitor drugs.
Flechner SM; Goldfarb D; Solez K; Modlin CS; Mastroianni B; Savas K; Babineau D; Kurian S; Salomon D; Novick AC; Cook DJ
Transplantation; 2007 Apr; 83(7):883-92. PubMed ID: 17460558
[TBL] [Abstract][Full Text] [Related]
15. Immunosuppression based on mycophenolate mofetil in stable liver transplanted patients.
Bilbao I; Castells L; Rojas L; Cancino J; Dopazo C; Castro E; Pou L; Andino R; Margarit C
Int Immunopharmacol; 2006 Dec; 6(13-14):1977-83. PubMed ID: 17161351
[TBL] [Abstract][Full Text] [Related]
16. Switch from calcineurin inhibitors to sirolimus-induced renal recovery in heart transplant recipients in the midterm follow-up.
Bestetti R; Theodoropoulos TA; Burdmann EA; Filho MA; Cordeiro JA; Villafanha D
Transplantation; 2006 Mar; 81(5):692-6. PubMed ID: 16534470
[TBL] [Abstract][Full Text] [Related]
17. Treatment strategies in pediatric solid organ transplant recipients with calcineurin inhibitor-induced nephrotoxicity.
Tönshoff B; Höcker B
Pediatr Transplant; 2006 Sep; 10(6):721-9. PubMed ID: 16911497
[TBL] [Abstract][Full Text] [Related]
18. Sirolimus immunosuppression in pediatric heart transplant recipients: a single-center experience.
Lobach NE; Pollock-Barziv SM; West LJ; Dipchand AI
J Heart Lung Transplant; 2005 Feb; 24(2):184-9. PubMed ID: 15701435
[TBL] [Abstract][Full Text] [Related]
19. Calcineurin-inhibitor free immunosuppression with mycophenolate mofetil and corticosteroids in paediatric renal transplantation improves renal allograft function without increasing acute rejection.
Krischock L; Gullett A; Bockenhauer D; Rees L; Trompeter RS; Marks SD
Pediatr Transplant; 2009 Jun; 13(4):475-81. PubMed ID: 18992054
[TBL] [Abstract][Full Text] [Related]
20. Tacrolimus and mycophenolate mofetil as first line immunosuppression after lung transplantation.
Neurohr C; Huppmann P; Zimmermann G; Leuchte H; Baumgartner R; Hatz R; Frey L; Uberfuhr P; Bittmann I; Behr J; Reichart B;
Transpl Int; 2009 Jun; 22(6):635-43. PubMed ID: 19207186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
